2020-12-02
Camurus AB today announced that Camurus licensee Braeburn has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) regarding its new drug application (NDA) for Brixadi.
Read the full press release: https://www.camurus.com/
2015-11-19
Camurus announces initial public offering on Nasdaq Stockholm. The company plans a new shares issue to a value of SE…
Read more2015-11-05
On November 3, 2015, Sandberg Development received Mazars prize for sustainable business. Per Sandberg was present a…
Read more2015-10-02
As of August 25, 2015 Kent Bengtsson started working as CFO in Sandberg Development.
Read more2015-09-17
GRANULDISK recently moved into new facilities in Malmö. The history behind the large-scale investment is strong grow…
Read more2015-06-22
In the wake of an extensive branding process, GS Development is changing its name to Sandberg Development AB. This p…
Read more